National Health Investors (NHI) reported a strong start to 2024, exceeding expectations in the first quarter. Key drivers included deferral repayments, revenue growth at NHC, stable rent concessions, and increased SHOP NOI. The company is raising its full-year guidance as a result.
Net income attributable to common stockholders per diluted common share was $0.71, compared to $0.79 in the same period last year.
NAREIT FFO per diluted common share was $1.10, compared to $1.16 in the prior year.
Normalized FFO per diluted common share was $1.12, compared to $1.11 in the prior year.
Normalized FAD was $51.0 million, compared to $47.7 million in the same period last year.
NHI is updating its 2024 annual guidance range.
Visualization of income flow from segment revenue to net income